The goal of this study is to determine whether markers of vascular inflammation (such as
c-reactive protein) can predict endothelial dysfunction (as measured by flow-mediated
dilation) in postmenopausal women with glucose intolerance compared to normal controls.
- healthy postmenopausal women
- ages 40-65
- diabetes requiring medication